 3. To obtain preliminary evidence of clinical efficacy of the combination of sipuleucel-T and low-protein diet compared to sipuleucel-T and control-diet, including objective response rate partial complete response, progression-free survival PFS and overall survival OS, and changes in prostate-specific antigen PSA. 